Community/Retail

Explore PREVENT Risk Equations reshaping hypertension care, HFpEF therapy, and CKD-related hyperkalemia.

Learn how COVID-19 drives heart and vascular risks, why vaccines and antivirals help, and how pharmacists manage dangerous drug interactions.

Orforglipron, an oral GLP-1 medication, demonstrated superior weight loss and blood glucose control compared with oral semaglutide in patients with type 2 diabetes (T2D).

Awareness of the nonlinear response helps ensure patients are treated with the least intensive regimen that achieves meaningful control while minimizing harm and improving long-term therapeutic success.

The oral solution improves central diabetes insipidus dosing precision, helping pharmacy teams tailor therapy, counsel patients, and monitor hyponatremia.

Collaborative practice agreements expand pharmacists’ clinical authority and patient access.

Flexibility, priorities, and structure are just as important as your account balance.

Comprehensive prevention and cardiometabolic risk control in prediabetes can reduce long-term complications, improve survival, and lower health system burden.

Pharmacy technicians drive patient care through smart, tech-enabled inventory management.

A new 4-pillar framework blends AI, real-time PDMP data, and social determinants of health to spot opioid misuse earlier and reduce overdoses.

FDA clears pegzilarginase-nbln enzyme therapy for ARG1-D, cutting toxic arginine and boosting mobility.

Laxmi Mehta, MD, discusses widespread patient unawareness of nonstatin cholesterol therapies, common statin misconceptions, and the critical role pharmacists play in bridging the lipid treatment knowledge gap.

See how prior authorization delays hit pharmacies first, and what state reforms—continuity rules, gold carding, ePA—can protect patient access.

FDA approves once-daily oral Wegovy for weight loss and long-term maintenance, matching injectable results while cutting cardiovascular event risk.

FDA clears oral Wegovy pills for weight loss, while Lemme Burn Gummies tout metabolic support; plus new thalassemia anemia drug and Lucentis biosimilar.

With this action, dupilumab has become the first and only FDA-approved treatment for allergic fungal rhinosinusitis.

The guideline establishes a novel clinical classification framework and recommends direct oral anticoagulants over vitamin K antagonists for eligible patients.

Canada’s experience demonstrates the risks of sidelining pharmacy in medical cannabis policy.

System-based safeguards reduce errors and harm from high-alert medications.

A 4-step pharmacist-led approach improves oral anticoagulant safety and outcomes.

Why smarter supply chain management protects patients and pharmacy operations

Preventing progression from prediabetes to type 2 diabetes improves patient outcomes while substantially reducing health system greenhouse gas emissions.

A new cohort study found that proteinuria and lower eGFR—particularly in combination—were prospectively associated with multiple domains of cognitive impairment in patients with chronic kidney disease (CKD).

Patient-centered pharmacist strategies improve safety, adherence, and outcomes in polypharmacy.

The authors urge air quality interventions to promote and support dementia prevention strategies.

Pharmacists boost late-season flu, COVID-19, and RSV vaccination with coadministration guidance, fatigue-fighting messaging, and community access strategies.

Over-the-counter misuse fuels drug-drug interactions and adverse events; see how pharmacists help shoppers choose safer OTC options, especially seniors.

A multicohort analysis reveals that obesity substantially increases hospitalization and mortality risk across diverse infectious diseases.